Clinical Trials Logo

Filter by:
NCT ID: NCT06464939 Not yet recruiting - Clinical trials for Dentin Hypersensitivity

Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity

Start date: August 19, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of KH001 in subjects with dentin hypersensitivity.

NCT ID: NCT04031664 Not yet recruiting - Clinical trials for Pelvic Inflammatory Diseases

A Clinical Study on Qianjin Capsule of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Damp-heat Stasis and Qi Deficiency Syndrome)

Start date: August 2, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety of Qianjin Capsule of Gynaecology combined with antibiotics for pelvic inflammatory diseases (Damp-heat Stasis and Qi Deficiency Syndrome) for the short-term and long-term efficacy of traditional Chinese medicine in reducing the use of antibiotics, reducing the risk of clinical use of drugs.

NCT ID: NCT04500093 Not yet recruiting - Muscle Weakness Clinical Trials

Does Capsulectomy, Performed in Total Hip Arthroplasty With a Direct Anterior Approach Cause Knee Extension Strength Loss?

Start date: August 2, 2020
Phase: N/A
Study type: Interventional

Total hip arthroplasty (THA) has been successful in relieving pain and restoring function in patients with advanced arthritis of the hip joint. Increased focus on earlier recovery and decreased postoperative pain has improved overall satisfaction. However, there is still a gap between the clinical scores in objective surveys and patient satisfaction. Direct anterior approach total hip arthroplasty has a low dislocation rate, abductor strength restoration, acceleration, and cosmetic advantages. In this method, capsulotomy with repair or capsulectomy is applied as the preferences of surgeons. Therefore, this can cause both a decrease in hip flexion strength and a loss in knee extension strength. Our aim in this study is to reveal how much muscle loss was caused by comparing both methods with the intact side.

NCT ID: NCT04919746 Not yet recruiting - Acupuncture Clinical Trials

Change in Dielectric Constant, Elasticity and Temperature by Acupuncture

Start date: August 2, 2021
Phase: N/A
Study type: Interventional

Evaluate the effect of systemic acupuncture on dielectric constant, elasticity and skin temperature in healthy individuals.

NCT ID: NCT04981769 Not yet recruiting - Covid19 Clinical Trials

POC SARS-CoV-2 Diagnostic PCR Device Comparison to FDA Approved Reference PCR Test

Start date: August 2, 2021
Phase:
Study type: Observational

Study will assess sensitivity and specificity of AnavasiDx POC PCR device for detection of Covid-19 in patients presenting for testing a clinical sites.

NCT ID: NCT04989933 Not yet recruiting - Sternotomy Pain Clinical Trials

Erector Spinae Plane Block With Two Different Volume for Open Heart Surgery

ESP
Start date: August 2, 2021
Phase: N/A
Study type: Interventional

The erector spine plane block is currently used in many surgeries to provide postoperative analgesia. It has also been used successfully in open-heart surgery for postoperative sternotomy pain. However, an ideal volume that will provide optimum analgesia has not yet been determined. This study aims to compare the effects of ESP block administered in two different volumes on poststernotomy pain.

NCT ID: NCT05385731 Not yet recruiting - Multiple Sclerosis Clinical Trials

MUSCLE - Nordic Walking in MUltiple SCLErosis

MUSCLE
Start date: August 2, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to analyze the effects of Nordic Walking and free walking in the clinical-functional, postural balance, motor control, muscular echographic quality, and gait analysis (pendulum gait mechanism), in people with Multiple Sclerosis.

NCT ID: NCT05463640 Not yet recruiting - AML Clinical Trials

Evaluate the Safety and Efficacy of ADGRE2 CAR-T in Patients With R/R AML

Start date: August 2, 2022
Phase: Phase 1
Study type: Interventional

This is an open label, phase I study to assess the safety and efficacy of ADGRE2 CAR-T in patients with relapsed and refractory acute myeloid leukemia

NCT ID: NCT05467254 Not yet recruiting - AML Clinical Trials

Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AML

Start date: August 2, 2022
Phase: Phase 1
Study type: Interventional

This is an open label, phase I study to assess the safety and efficacy of CLL1+CD33 CAR-T in patients with relapsed and refractory acute myeloid leukemia

NCT ID: NCT05473221 Not yet recruiting - AML Clinical Trials

Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AML

Start date: August 2, 2022
Phase: Phase 1
Study type: Interventional

This is an open label, phase I study to assess the safety and efficacy of CD33 CAR-T in patients with relapsed and refractory acute myeloid leukemia